https://www.pharmalive.com/wp-content/uploads/2021/03/GSK-and-Vir-seek-emergency-use-of-COVID-19-therapy-in-United-States-Reuters-3-26-21.jpeg 234 369 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-03-25 22:45:442022-03-25 23:59:34FDA says current dose of GSK-Vir COVID therapy unlikely to work against BA.2 variant
FDA says current dose of GSK-Vir COVID therapy unlikely to work against BA.2 variant
March 25, 2022; 5:34 PM EDT
Reporting by Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber
Our Standards: The Thomson Reuters Trust Principles.